142 related articles for article (PubMed ID: 29804717)
1. High expression of QSOX1 is associated with tumor invasiveness and high grades groups in prostate cancer.
Baek JA; Song PH; Ko Y; Gu MJ
Pathol Res Pract; 2018 Jul; 214(7):964-967. PubMed ID: 29804717
[TBL] [Abstract][Full Text] [Related]
2. Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancer.
Katchman BA; Ocal IT; Cunliffe HE; Chang YH; Hostetter G; Watanabe A; LoBello J; Lake DF
Breast Cancer Res; 2013 Mar; 15(2):R28. PubMed ID: 23536962
[TBL] [Abstract][Full Text] [Related]
3. Quiescin Sulfhydryl Oxidase 1 (QSOX1) Secreted by Lung Cancer Cells Promotes Cancer Metastasis.
Sung HJ; Ahn JM; Yoon YH; Na SS; Choi YJ; Kim YI; Lee SY; Lee EB; Cho S; Cho JY
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30336636
[TBL] [Abstract][Full Text] [Related]
4. Quiescin sulfhydryl oxidase 1 promotes invasion of pancreatic tumor cells mediated by matrix metalloproteinases.
Katchman BA; Antwi K; Hostetter G; Demeure MJ; Watanabe A; Decker GA; Miller LJ; Von Hoff DD; Lake DF
Mol Cancer Res; 2011 Dec; 9(12):1621-31. PubMed ID: 21989104
[TBL] [Abstract][Full Text] [Related]
5. QSOX1 expression is associated with aggressive tumor features and reduced survival in breast carcinomas.
Knutsvik G; Collett K; Arnes J; Akslen LA; Stefansson IM
Mod Pathol; 2016 Dec; 29(12):1485-1491. PubMed ID: 27562495
[TBL] [Abstract][Full Text] [Related]
6. Ebselen inhibits QSOX1 enzymatic activity and suppresses invasion of pancreatic and renal cancer cell lines.
Hanavan PD; Borges CR; Katchman BA; Faigel DO; Ho TH; Ma CT; Sergienko EA; Meurice N; Petit JL; Lake DF
Oncotarget; 2015 Jul; 6(21):18418-28. PubMed ID: 26158899
[TBL] [Abstract][Full Text] [Related]
7. High expression of QSOX1 reduces tumorogenesis, and is associated with a better outcome for breast cancer patients.
Pernodet N; Hermetet F; Adami P; Vejux A; Descotes F; Borg C; Adams M; Pallandre JR; Viennet G; Esnard F; Jouvenot M; Despouy G
Breast Cancer Res; 2012 Oct; 14(5):R136. PubMed ID: 23098186
[TBL] [Abstract][Full Text] [Related]
8. Sulfiredoxin as a Potential Therapeutic Target for Advanced and Metastatic Prostate Cancer.
Barquilha CN; Santos NJ; Monção CCD; Barbosa IC; Lima FO; Justulin LA; Pértega-Gomes N; Felisbino SL
Oxid Med Cell Longev; 2020; 2020():2148562. PubMed ID: 32411320
[TBL] [Abstract][Full Text] [Related]
9. Prostate specific G protein coupled receptor is associated with prostate cancer prognosis and affects cancer cell proliferation and invasion.
Cao W; Li F; Yao J; Yu J
BMC Cancer; 2015 Nov; 15():915. PubMed ID: 26582057
[TBL] [Abstract][Full Text] [Related]
10. The loss of CD44 and HSP70 overexpression is related to aggressive clinicopathologic factors in prostate cancer.
Baek JA; Choi JH; Gu MJ
Int J Clin Exp Pathol; 2018; 11(11):5466-5472. PubMed ID: 31949631
[TBL] [Abstract][Full Text] [Related]
11. Elevated transcription of the gene QSOX1 encoding quiescin Q6 sulfhydryl oxidase 1 in breast cancer.
Soloviev M; Esteves MP; Amiri F; Crompton MR; Rider CC
PLoS One; 2013; 8(2):e57327. PubMed ID: 23460839
[TBL] [Abstract][Full Text] [Related]
12. Expression level of quiescin sulfhydryl oxidase 1 (QSOX1) in neuroblastomas.
Araújo DG; Nakao L; Gozzo P; Souza CD; Balderrama V; Gugelmin ES; Kuczynski AP; Olandoski M; de Noronha L
Eur J Histochem; 2014 Mar; 58(1):2228. PubMed ID: 24704990
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of endothelial cell marker CD34 and mast cell marker CD117 in prostate adenocarcinoma.
Foroozan M; Roudi R; Abolhasani M; Gheytanchi E; Mehrazma M
Pathol Res Pract; 2017 Jun; 213(6):612-618. PubMed ID: 28552539
[TBL] [Abstract][Full Text] [Related]
14. Role of tumor-associated macrophages in the Hexim1 and TGFβ/SMAD pathway, and their influence on progression of prostatic adenocarcinoma.
Ok Atılgan A; Özdemir BH; Akçay EY; Ataol Demirkan Ö; Tekindal MA; Özkardeş H
Pathol Res Pract; 2016 Feb; 212(2):83-92. PubMed ID: 26608417
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of sulfhydryl oxidase (QSOX1) in pediatric medulloblastomas.
Sobral AC; Neto VM; Traiano G; Percicote AP; Gugelmin ES; de Souza CM; Nakao L; Torres LF; de Noronha L
Diagn Pathol; 2015 Apr; 10():37. PubMed ID: 25908093
[TBL] [Abstract][Full Text] [Related]
16. TGF Beta1 Expression Correlates with Survival and Tumor Aggressiveness of Prostate Cancer.
Wu CT; Chang YH; Lin WY; Chen WC; Chen MF
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1587-93. PubMed ID: 26271396
[TBL] [Abstract][Full Text] [Related]
17. The emerging role of QSOX1 in cancer.
Lake DF; Faigel DO
Antioxid Redox Signal; 2014 Jul; 21(3):485-96. PubMed ID: 24359107
[TBL] [Abstract][Full Text] [Related]
18. Putative prognostic epithelial-to-mesenchymal transition biomarkers for aggressive prostate cancer.
Whiteland H; Spencer-Harty S; Thomas DH; Davies C; Morgan C; Kynaston H; Bose P; Fenn N; Lewis PD; Bodger O; Jenkins S; Doak SH
Exp Mol Pathol; 2013 Oct; 95(2):220-6. PubMed ID: 23933194
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers.
Burdelski C; Fitzner M; Hube-Magg C; Kluth M; Heumann A; Simon R; Krech T; Clauditz T; Büscheck F; Steurer S; Wittmer C; Hinsch A; Luebke AM; Jacobsen F; Minner S; Tsourlakis MC; Beyer B; Steuber T; Thederan I; Sauter G; Izbicki J; Schlomm T; Wilczak W
Neoplasia; 2017 Apr; 19(4):279-287. PubMed ID: 28282546
[TBL] [Abstract][Full Text] [Related]
20. Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer.
Kojima Y; Yoneyama T; Hatakeyama S; Mikami J; Sato T; Mori K; Hashimoto Y; Koie T; Ohyama C; Fukuda M; Tobisawa Y
PLoS One; 2015; 10(9):e0138520. PubMed ID: 26390303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
